Revance Therapeutics, Inc. Gains 21.58%

Thu, Sep 08, 2022 at 07:25 PM
Revance Therapeutics, Inc. Gains 21.58%

Revance Therapeutics, Inc. (RVNC:NASDAQ) soared at $25.3, representing a gain of 21.6%. On Thu, Sep 08, 2022, RVNC:NASDAQ touched a New 2-Week High of $25.3. The stock appeared on our News Catalysts scanner on Thu, Sep 08, 2022 at 11:43 AM in the 'BIOTECH' category. From Thu, Aug 25, 2022, the stock recorded 77.78% Up Days and 60.00% Green Days

About Revance Therapeutics, Inc. (RVNC:NASDAQ)

Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.